Weight Loss With Subcutaneous Semaglutide Versus Other Glucagon Like Peptide-1 Receptor Agonists In Type 2 Diabetes: A Systematic Review.
Brandon StrettonJoshua G KovoorStephen BacchiShantel ChangBenjamin NgoiTess MurrayThomas Cameron BristowJonathan HengAashray GuptaChristopher OvendenGuy MaddernCampbell Henry ThompsonLeonie HeilbronnMark BoydChristopher RaynerNicholas J TalleyMichael HorowtizPublished in: Internal medicine journal (2023)
There is evidence that semaglutide is superior to other GLP-1RAs for inducing weight loss in T2DM, but is less effective than tirzepatide. This article is protected by copyright. All rights reserved.